drugset
drugset / Trial / NCT03255629

Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia

NCT03255629 ↗

Phase 1/2 Completed 18 enrolled Joslin Diabetes Center Harvard University · collabNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collabNational Institutes of Health (NIH) · collabXeris Pharmaceuticals · collab
RandomizedCrossoverQuadruple-blindPrevention

Summary

To assess the efficacy of a closed loop glucagon system to prevent and treat hypoglycemia occurring in patients with Post-Bariatric Hypoglycemia (PBH) in response to meals and exercise.

Timeline

Start
2017-09-19
Primary completion
2018-08-22
Completion
2018-08-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucagon Peptide — —

Indications

postgastrectomy syndrome